Pacritinib: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

2 February 2024

  • curprev 15:4815:48, 2 February 2024‎ Edzelco talk contribs‎ 29,297 bytes −2‎ No edit summary
  • curprev 15:4715:47, 2 February 2024‎ Edzelco talk contribs‎ 29,299 bytes +29,299‎ Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=Pacritinib |aOrAn=a |drugClass=kinase inhibitor |indicationType=treatment |indication=adults with intermediate or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis with a platelet count below 50 × 109/L (1) |adverseReactions=diarrhea, thrombocytopenia, nausea, anemia, and peripheral edema |fdaLIADAdult=The recommended dosage of VONJO is 200 mg orally twi..."
Retrieved from "https://www.wikidoc.org/index.php/Pacritinib"